Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic and inflammatory rheumatic disease that leads to inflammation of the joints and surrounding tissues. Identification of novel protein(s) associated with severity of RA is a prerequisite for better understanding of pathogenesis of this disease that may also have potential to serve as novel biomarkers in the diagnosis of RA. Present study was undertaken to compare the amount of autoantigens and autoantibodies in the plasma of RA patients in comparison to healthy controls. Plasma samples were collected from the patients suffering from RA, Osteoarthritis (OA), Systemic lupus erythematosus (SLE) and healthy volunteers. The screening of plasma proteins were carried out using 2-dimensional gel electrophoresis followed by identification of differentially expressed protein by MALDI-TOF MS/MS. Among several differentially expressed proteins, transthyretin (TTR) has been identified as one of the protein that showed significantly up regulated expression in the plasma of RA patients. The results were further validated by Western blot analysis and ELISA. In comparison to OA synovium, an exclusive significantly high expression of TTR in RA has been validated through IHC, Western blotting and IEM studies. Most importantly, the increase in expression of TTR with the progression of severity of RA condition has been observed. The autoantibodies against TTR present in the RA plasma were identified using immunoprecipitation-Western methods. The significant production of autoantibodies was validated by ELISA and Western blot analysis using recombinant pure protein of TTR. Hence, these novel observations on increase in TTR expression with the increase in severity of RA conditions and significant production of autoantibodies against TTR clearly suggest that a systematic studies on the role TTR in the pathogenesis of RA is immediately required and TTR may be used as a serum diagnostic marker together with other biochemical parameters and clinical symptoms for RA screening and diagnosis.
References
[1]
Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2: 473–488. doi: 10.1038/nrd1109
[2]
Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52: S39–S47. doi: 10.1136/ard.52.suppl_1.s39
[3]
Mittler RS (2004) Suppressing the self in rheumatoid arthritis. Nat Med 10: 1047–1049. doi: 10.1038/nm1004-1047
[4]
Bromberg J (2013) TNFα trips up Treg cells in rheumatoid arthritis. Nat Med 19: 269–270. doi: 10.1038/nm.3124
[5]
Wolfe F (1997a) The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med 103: 12–18. doi: 10.1016/s0002-9343(97)90003-6
[6]
Snir O, Widhe M, Hermansson M, VonSpee C, Linderberg J, et al. (2010) Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 62: 44–52. doi: 10.1002/art.25036
[7]
Ziff M (1990) Rheumatoid arthritis-its present and future. J Rheumatol 17: 127–133.
[8]
Liao H, Wu J, Kuhn E, Chin W, Chang B, et al. (2004) Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50: 3792–3803. doi: 10.1002/art.20720
[9]
Wang J, Zhou N, Xu B, Hao H, Kang L, et al. (2012) Identification and Cluster Analysis of Streptococcus pyogenes by MALDI-TOF Mass Spectrometry. PloS One 7: e0047152. doi: 10.1371/journal.pone.0047152
[10]
Marchi N, Fazio V, Cucullo L, Kight K, Asaryk T, et al. (2003) Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J Neurosci 23: 1949–1955.
[11]
Davis PJ, Handwerger BS, Gregerman RI (1972) Thyroid hormone binding by human serum prealbumin (TBPA) electrophoretic studies of triiodothyronine-TBPA interaction. J Clin Invest 51: 515–521. doi: 10.1172/jci106839
[12]
Kanai M, Raz A, Goodman DS (1968) Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 47: 2025–2044. doi: 10.1172/jci105889
[13]
Peterson PA (1971) Characteristics of a vitamin A-transporting protein complex occurring in human serum. J Biol Chem 246: 34–43.
[14]
Berry DC, Croniger CM, Ghyselinck NB (2012) Noya (2012) Transthyretin Blocks Retinol Uptake and Cell Signaling by the Holo-Retinol-Binding Protein Receptor STRA6. Mol Cell Biol 19: 3851–3859. doi: 10.1128/mcb.00775-12
[15]
Gitlin D, Perricelli A (1970) Synthesis of serum albumin, prealbumin, alpha-fetoprotein, alpha-1-antitrypsin and transferrin by the human yolk sac. Nature 228: 995–997. doi: 10.1038/228995a0
[16]
Chang X, Zhao Y, Wang Y, Chen Y, Yan X (2013) Screening citrullinated proteins in synovial tissues of rheumatoid arthritis using 2-dimensional western blotting. J Rheumatol 40: 219–27. doi: 10.3899/jrheum.120751
[17]
Saroha A, Kumar S, Chatterjee BP, Das HR (2012) Jacalin bound plasma O-glycoproteome and reduced sialylation of alpha 2-HS glycoprotein in rheumatoid arthritis patients. PloS One 7: e46374. doi: 10.1371/journal.pone.0046374
[18]
Biswas S, Sharma S, Saroha A, Bhakuni DS, Malhotra R, et al. (2013) Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PloS One 8: e56246. doi: 10.1371/journal.pone.0056246
[19]
Bo GP, Zhou LN, He WF, Luo GX, Jia XF, et al. (2009) Analyses of differential proteome of human synovial fibroblasts obtained from arthritis. Clin Rheumatol 28: 191–199. doi: 10.1007/s10067-008-1013-y
[20]
Hueber W, Tomooka BH, Batliwalla F, Li W, Monach PA, et al. (2009) Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Res Ther 11: R76. doi: 10.1186/ar2706
[21]
Ahmad A, Mukherjee S, Pattnaik B, Kumar M, Singh S, et al. (2014) Miro1 regulates intracellular mitochondrial transport and enhances mesenchymal stem cell rescue efficacy. EMBO J "In press". doi: 10.1002/embj.201386030
[22]
Smith RM, Charron MJ, Shah N, Lodish HF (1991) Immunoelectron microscopic demonstration of insulin-stimulated translocation of glucose transporters of plasma membrane of isolated rat adipocytes and masking of carboxy-terminal epitope of intracellular GLUT-4. Proc Natl Acad Sci U S A 88: 6893–6897. doi: 10.1073/pnas.88.15.6893
[23]
Riveraa J, Cordeora RB, Nakouzia AS, Frasesb S, Nicolaa A, et al. (2010) Bacillus anthracis produces membrane–derived vesicle containing biologically active toxins. Proc Natl Acad Sci, U S A 107: 19002–19007.
[24]
Johnson AM, Merlini G, Sheldon J, Ichihara K (2007) Clinical indications of plasma protein assays: transthyretin (prealbnumin) in inflammation and malnutrition. Clin Chem Lab Med 47: 419–426.
[25]
Sekine T, Masuko-Hongo K, Matsui T, Asahara H, Takigawa M, et al. (2001) Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis 60: 49–54. doi: 10.1136/ard.60.1.49
[26]
Tsuruha J, Masuko-Hongo K, Kato T, Sakata M, Nakamura H, et al. (2001) Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 44: 838–845. doi: 10.1002/1529-0131(200104)44:4<838::aid-anr140>3.3.co;2-3
[27]
Iwaki-Egawa S, Matsuno H, Yudoh K, Nakazawa F, Miyazaki K, et al. (2004) High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen. J Rheumatol 31: 17–22.
[28]
Westhoff CM (2007) The structure and function of the Rh antigen complex. Semin Hematol 44: 42–50. doi: 10.1053/j.seminhematol.2006.09.010
[29]
Drake RR, Cazares LH, Semmens OJ, Wardsworth JT (2005) Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Expert Rev Mol Diagn 5: 93–100. doi: 10.1586/14737159.5.1.93
[30]
Karpova MA, Moshkovskii SA, Toropygin IY, Archakov AI (2010) Cancer specific MALDI-TOF profile of blood serum and plasma: Biological meaning and perspectives. J Proteomics 73: 537–551. doi: 10.1016/j.jprot.2009.09.011
[31]
Howard BA, Wang MZ, Campa MJ, Corro C, Fitzgerald MC, et al. (2003) Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization- time of flight spectra analysis. Proteomics 9: 1720–1724. doi: 10.1002/pmic.200300514
[32]
Zheng Y, Xu Y, Ye B, Lei J, Weinstein MH (2003) Prostate carcinoma tissue proteomics for biomarker discovery. Cancer 15: 2576–2582. doi: 10.1002/cncr.11849
[33]
Trocme C, Marotee H, Baillet A, Pallot-Prades B, Garin J, et al. (2009) Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis. Ann Rheum Dis 68: 1328–1333. doi: 10.1136/ard.2008.093153
[34]
Niu Q, Huang Z, Shi Y, Wang L, Pan X, et al. (2010) Specific serum protein biomarkers of rheumatoid arthritis detected by MALDI-TOF-MS combined with magnetic beads. Int Immunol 22: 611–618. doi: 10.1093/intimm/dxq043
[35]
Ni M, Wei W, Feng Q, Sun XG, Wang YC, et al. (2013) Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis. Clin Exp Rheumatol 31: 394–399.
[36]
Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, et al. (2005) Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 5: 4589–4596. doi: 10.1002/pmic.200500093
[37]
Feng JT, Liu YK, Song HY, Dai Z, Qin LX, et al. (2005) Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5: 4581–4588. doi: 10.1002/pmic.200401309
[38]
Marten NW, Sladek FM, Straus DS (1996) Effect of dietary protein restriction on liver transcription factors. Biochem J 317: 361–370.
[39]
Escher N, Kaatzy M, Melle C, Hiplery C, Ziemery M, et al. (2007) Posttranslational modifications of Transthyretin are serum markers in patients with Mycosis Fungoides. Neoplasia 9: 254–259. doi: 10.1593/neo.06805
